Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Joel Greenblatt’s Top Picks Include United Therapeutics and Activision Blizzard

One of the funds we track is Joel Greenblatt‘s Gotham Asset Management, which recently filed its 13F form, disclosing its equity portfolio as at the end of the third quarter of the year. The fund’s largest holding is United Therapeutics Corporation (NASDAQ:UTHR). Gotham holds currently 372,147 shares of the company, the value of the position amounting to around $29.3 million. In Activision Blizzard, Inc. (NASDAQ:ATVI), Greenblatt’s fund reported a $24.4 million stake which amasses almost 1.5 million shares. GOTHAM ASSET MANAGEMENT The next on the list is Endo Health Solutions Inc (NASDAQ:ENDP), represented in Gotham’s 13F by a $23.7 million stake, and Warner Chilcott Plc (NASDAQ:WCRX), in which Gotham holds a $23.5 million position, which amasses over 1.02 million shares. And the last of the top five is PDL BioPharma Inc. (NASDAQ:PDLI), Gotham owning around 2.9 million shares, worth slightly above $23 million.

Disclosure: none